Cisplatin Interactions
There are 463 drugs known to interact with cisplatin, along with 7 disease interactions. Of the total drug interactions, 89 are major, 355 are moderate, and 19 are minor.
- View all 463 medications that may interact with cisplatin
- View cisplatin disease interactions (7)
Most frequently checked interactions
View interaction reports for cisplatin and the medicines listed below.
- Adriamycin (doxorubicin)
- Adriamycin (doxorubicin)
- Ativan (lorazepam)
- Ativan (lorazepam)
- Avastin (bevacizumab)
- Avastin (bevacizumab)
- Compazine (prochlorperazine)
- Compazine (prochlorperazine)
- Cytoxan (cyclophosphamide)
- Cytoxan (cyclophosphamide)
- Decadron (dexamethasone)
- Decadron (dexamethasone)
- Gemzar (gemcitabine)
- Gemzar (gemcitabine)
- Metoprolol Succinate ER (metoprolol)
- Metoprolol Succinate ER (metoprolol)
- Quercetin (bioflavonoids)
- Quercetin (bioflavonoids)
- Taxol (paclitaxel)
- Taxol (paclitaxel)
- Tylenol (acetaminophen)
- Tylenol (acetaminophen)
- Vitamin B12 (cyanocobalamin)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin C (ascorbic acid)
- Vitamin D3 (cholecalciferol)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
- Zofran (ondansetron)
Cisplatin disease interactions
There are 7 disease interactions with cisplatin which include:
- infections
- hearing loss
- myelosuppression
- peripheral neuropathy
- renal dysfunction
- hemolytic anemia
- ocular toxicity
Report options
More about cisplatin
- cisplatin consumer information
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: alkylating agents
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Loqtorzi
Loqtorzi (toripalimab-tpzi) is a PD-1 inhibitor medicine used for the treatment of advanced ...
Opdivo Qvantig
Opdivo Qvantig is used to treat adults with melanoma, non-small cell lung cancer, renal cell ...
Enhertu
Enhertu is a treatment for breast cancer, stomach cancer, and non-small cell lung cancer with HER2 ...
Rybrevant
Rybrevant is used to treat advanced non-small cell lung cancer (NSCLC) in adults that has certain ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Keytruda
Keytruda is used to treat melanoma, non-small cell lung cancer, malignant pleural mesothelioma ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Imfinzi
Imfinzi (durvalumab) is an immunotherapy used to treat types of lung cancer (NSCLC, SCLC), bile ...
Padcev
Padcev (enfortumab vedotin) is an antibody-drug conjugate that is given as an intravenous infusion ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.